JYJianming Ye

Jianming Ye

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jianming Ye has a total of 44 co-authors. Here are the top co-authors by number of shared publications:

  • Xiangcai Wang

    Department of Oncology, The First Affiliated Hospital, Jiangxi Clinical Research Center for Cancer, Gannan Medical University, Ganzhou, China

    5 shared publications
  • An Li

    Department of Oncology, The First Affiliated Hospital of Gannan Medical University

    4 shared publications
  • Xiaobo Lai

    School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, China

    4 shared publications
  • Xiaoli Zeng

    Department of Oncology, The First Affiliated Hospital of Gannan Medical University

    4 shared publications
  • Xiaoting Zhong

    Department of Oncology, The First Affiliated Hospital of Gannan Medical University

    4 shared publications
  • Chunli Wang

    Intensive Care Unit, First Affiliated Hospital, Gannan Medical University Ganzhou 341000, Jiangxi, China

    3 shared publications

Latest Publications

  • Open Access

    Megestrol acetate in the management of cancer cachexia: a prospective quasi-experimental study focusing on body composition and patient-reported outcomes

    by Xiaoting Zhong, Boyang Kuang, Kuan Yang, Huang Zhou, Chenxi Yuan, Xiangcai Wang, Hongmei Chen, Xiaoli Zeng, An Li, Weiling Lai, et al.

    Background: The objective of this study is to investigate the efficacy of megestrol acetate (MA) in treating cancer cachexia from multiple dimensions. Methods: In this prospective, non-randomized study, 97 patients with cancer cachexia were allocated to either a control group ( n = 33, regular diet) or an MA group ( n = 64, regular diet plus MA 320 mg/day) for 2 months. The primary endpoints were nutritional indices, including weight, BMI, total skeletal muscle mass, and fat mass. Secondary endpoints included inflammatory markers (CRP, IL-6, TNF- α ), immune parameters (CD4 + , CD8 + T cells), cancer-related fatigue (assessed by the Cancer Fatigue Scale), and quality of life (QOL). Results: Compared to baseline, the MA group exhibited significant improvements in body weight, BMI, fat mass, prealbumin (PA), albumin (ALB), and hemoglobin (Hb), coupled with a significant reduction in IL-6 levels and all domains of cancer-related fatigue (somatic, cognitive, affective, and total). Between-group analyses demonstrated that the MA group achieved significantly greater improvements in weight, BMI, fat mass, PA, ALB, and Hb. Skeletal muscle mass was maintained in the MA group, whereas the control group experienced a significant loss, resulting in a significant between-group difference. Furthermore, the MA group showed markedly greater reductions in all fatigue domain scores and a more substantial improvement in QOL. No significant between-group differences were observed for most inflammatory or immune markers. The intervention was well-tolerated with no reported drug-related adverse events. Conclusion: MA significantly improves nutritional status and ameliorates cancer-related fatigue, thereby enhancing the quality of life in patients with cancer cachexia. Our findings provide robust evidence supporting the multi-dimensional benefits of MA in cachexia management, extending beyond mere weight gain to include muscle mass preservation and patient-centered symptom relief.

  • Open Access

    Celecoxib in oncology: targeting the COX-2/PGE2 axis to reprogram the tumor immune microenvironment and enhance multimodal therapy

    by Boyang Kuang, Kuan Yang, Xiaoting Zhong, Yingwei Tan, Yi Zhou, Jianming Ye

    Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, has emerged as a multifaceted therapeutic agent in oncology due to its dual anti-inflammatory and antitumor properties. This review synthesizes recent advances in understanding the molecular mechanisms and clinical applications of celecoxib in cancer treatment. Celecoxib not only hinders the proliferation and metastasis of tumor cells by inhibiting COX-2 synthesis, but also inhibits the intratumoral infiltration of regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs) and activates cytotoxic T cells, thereby reshaping the inhibitory immune microenvironment. Preclinical and clinical studies demonstrate its synergistic effects with chemotherapy, radiotherapy, and immunotherapy, particularly in augmenting immune checkpoint blockade efficacy. Despite the breakthrough of celecoxib in the field of oncology treatment, large-scale trials are warranted to validate its long-term safety and biomarker-driven accuracy. This work underscores the potential of celecoxib as a cornerstone in multimodal cancer therapy and provides a roadmap for its integration into personalized treatment paradigms.


  • Chemotherapy-induced suppression of colorectal cancer-associated gut microbiota and modulation of host miRNA expression

    by Chunli Wang, Baoyang Kuang, Kuan Yang, Xuewen Xiao, Caixia Wu, An Li, Xiaoli Zeng, Xiangcai Wang, Jianming Ye

    Objectives: To characterize gut microbiome alterations in colorectal cancer (CRC) patients following cancer chemotherapy (CCT) and to explore associations with bacterial translocation and host miRNA dynamics. Methods: Stool samples were prospectively collected from 20 CRC patients who had undergone radical surgery followed by adjuvant chemotherapy (CAPOX/mFOLFOX6). Stool samples were collected pre- and post-CCT. Microbial profiling was performed using 16S rRNA sequencing. Bacterial translocation was assessed by measuring serum anti-Lipopolysaccharides (LPS) IgA/IgG levels by ELISA. miRNA expression of miR-143 and miR-145 was quantified using qPCR. Results: Post-CCT samples showed significant increases in gut microbiome diversity (P<0.05), with higher relative abundances of Porphyromonas, Peptostreptococcus, and Parvimonas, and decreased abundances of Faecalibacterium and Ruminococcaceae (P<0.005). Network analysis identified Peptostreptococcus and Parvimonas as possible CRC-associated taxa. Serum anti-LPS IgA and IgG levels significantly declined post-CCT, indicating reduced bacterial translocation. Concurrently, miR-143 and miR-145 levels increased more than twofold post-CCT (P<0.01), positively correlating with microbial shifts. Conclusion: CCT induces significant remodeling of CRC-associated gut microbiota, characterized by suppression of pathogenic genera and enrichment of pro-inflammatory taxa. These changes align with reduced bacterial translocation and increased expression of tumor-suppressive miRNAs, suggesting that CCT exerts dual therapeutic effects by simultaneously modulating microbial communities and host molecular pathways.


  • Open Access

    Syntaxin6 contributes to hepatocellular carcinoma tumorigenesis via enhancing STAT3 phosphorylation

    by Li Huang, Xiaoting Zhong, An Li, Fuping Tu, Miao He, Xueming Xu, Xiaohui Liu, Xiaoli Zeng, Jun Chi, Tian Tian, et al.

    Background: Syntaxin6 (STX6) is a SNARE (Soluble N-ethylmaleimide-sensitive factor attachment protein receptors) protein complex located in the trans-Golgi network and endosomes, which is closely associated with a variety of intracellular membrane transport events. STX6 has been shown to be overexpressed in a variety of human malignant tumors such as esophageal, colorectal, and renal cell carcinomas, and participates in tumorigenesis and development. Methods: Based on clinical public database and clinical liver samples analysis, the expression of STX6 in hepatocellular carcinoma (HCC) tissues was investigated. The effects of STX6 on proliferation, migration and invasion of HCC cell in vitro and in vivo were evaluated through gain- and loss-of-function studies. We further performed RNA-seq analysis and protein interactome analysis, to further decifer the detailed mechanisms of STX6 in the regulation of the JAK-STAT pathway in HCC. Results: STX6 expression was upregulated in HCC tissues and its expression was highly correlated with the high histological grade of the tumor. STX6 promoted HCC cell proliferation, migration and invasion both in vitro and in vivo. Mechanistically, STX6 mediated tumor progression depending on promoting the activation of JAK-STAT signaling pathway. Receptor for activated protein kinase C (RACK1) as an essential adaptor protein mediating STX6 regulation of JAK-STAT pathway. Specifically, STX6 interacted with RACK1 and then recruited signal transducer and activator of transcription 3 (STAT3) to form a protein-binding complex and activates STAT3 transcriptional activity. Conclusions: This study provided a novel concept that STX6 exerted oncogenic effects by activating the STAT3 signaling pathway, and STX6 might be a promising therapeutic target for HCC.


  • Open Access

    Syntaxin6 contributes to hepatocellular carcinoma tumorigenesis via enhancing STAT3 phosphorylation

    by Li Huang, Xiaoting Zhong, An Li, Fuping Tu, Miao He, Xueming Xu, Xiaohui Liu, Xiaoli Zeng, Jun Chi, Tian Tian, et al.

    Background Syntaxin6 (STX6) is a SNARE (Soluble N-ethylmaleimide-sensitive factor attachment protein receptors) protein complex located in the trans-Golgi network and endosomes, which is closely associated with a variety of intracellular membrane transport events. STX6 has been shown to be overexpressed in a variety of human malignant tumors such as esophageal, colorectal, and renal cell carcinomas, and participates in tumorigenesis and development. Methods Based on clinical public database and clinical liver samples analysis, the expression of STX6 in hepatocellular carcinoma (HCC) tissues was investigated. The effects of STX6 on proliferation, migration and invasion of HCC cell in vitro and in vivo were evaluated through gain- and loss-of-function studies. The role of receptor for activated protein kinase C (RACK1) in mediating STX6 regulation of the JAK-STAT pathway was identified by protein interactome analysis. Results STX6 expression was upregulated in HCC tissues and its expression was highly correlated with the high histological grade of the tumor. STX6 promoted HCC cell proliferation, migration and invasion both in vitro and in vivo. Mechanistically, STX6 mediated tumor progression depending on promoting the activation of JAK-STAT signaling pathway. RACK1 as an essential adaptor protein mediating STX6 regulation of JAK-STAT pathway. Specifically, STX6 interacted with RACK1 and then recruited signal transducer and activator of transcription 3 (STAT3) to form a protein-binding complex and activates STAT3 transcriptional activity. Conclusions This study provided a novel concept that STX6 exerted oncogenic effects by activating the STAT3 signaling pathway, and STX6 might be a promising therapeutic target for HCC.

  • Open Access

    Combined Channel Attention and Spatial Attention Module Network for Chinese Herbal Slices Automated Recognition

    by Jianqing Wang, Weitao Mo, Yan Wu, Xiaomei Xu, Yi Li, Jianming Ye, Xiaobo Lai

    Chinese Herbal Slices (CHS) are critical components of Traditional Chinese Medicine (TCM); the accurate recognition of CHS is crucial for applying to medicine, production, and education. However, existing methods to recognize the CHS are mainly performed by experienced professionals, which may not meet vast CHS market demand due to time-consuming and the limited number of professionals. Although some automated CHS recognition approaches have been proposed, the performance still needs further improvement because they are primarily based on the traditional machine learning with hand-crafted features, resulting in relatively low accuracy. Additionally, few CHS datasets are available for research aimed at practical application. To comprehensively address these problems, we propose a combined channel attention and spatial attention module network (CCSM-Net) for efficiently recognizing CHS with 2-D images. The CCSM-Net integrates channel and spatial attentions, focusing on the most important information as well as the position of the information of CHS image. Especially, pairs of max-pooling and average pooling operations are used in the CA and SA module to aggregate the channel information of the feature map. Then, a dataset of 14,196 images with 182 categories of commonly used CHS is constructed. We evaluated our framework on the constructed dataset. Experimental results show that the proposed CCSM-Net indicates promising performance and outperforms other typical deep learning algorithms, achieving a recognition rate of 99.27%, a precision of 99.33%, a recall of 99.27%, and an F1-score of 99.26% with different numbers of CHS categories.


  • Open Access

    OTO-Net: An Automated MRA Image Segmentation Network for Intracranial Aneurysms

    by Jianming Ye, Xiaomei Xu, Liuyi Li, Jialu Zhao, Weiling Lai, Wenting Zhou, Chong Zheng, Xiangcai Wang, Xiaobo Lai

    Intracranial aneurysms are local dilations of the cerebral blood vessels; people with intracranial aneurysms have a high risk to cause bleeding in the brain, which is related to high mortality and morbidity rates. Accurate detection and segmentation of intracranial aneurysms from Magnetic Resonance Angiography (MRA) images are essential in the clinical routine. Manual annotations used to assess the intracranial aneurysms on MRA images are substantial interobserver variability for both aneurysm detection and assessment of aneurysm size and growth. Many prior automated segmentation works have focused their efforts on tackling the problem, but there is still room for performance improvement due to the significant variability of lesions in the location, size, structure, and morphological appearance. To address these challenges, we propose a novel One-Two-One Fully Convolutional Networks (OTO-Net) for intracranial aneurysms automated segmentation in MRA images. The OTO-Net uses full convolution to achieve intracranial aneurysms automated segmentation through the combination of downsampling, upsampling, and skip connection. In addition, loss ensemble is used as the objective function to steadily improve the backpropagation efficiency of the network structure during the training process. We evaluated the proposed OTO-Net on one public benchmark dataset and one private dataset. Our proposed model can achieve the automated segmentation accuracy with 98.37% and 97.86%, average surface distances with 1.081 and 0.753, dice similarity coefficients with 0.9721 and 0.9813, and Hausdorff distance with 0.578 and 0.642 on these two datasets, respectively.


  • Open Access

    Automated Segmentation of Mass Regions in DBT Images Using a Dilated DCNN Approach

    by Jianming Ye, Weiji Yang, Jianqing Wang, Xiaomei Xu, Liuyi Li, Chun Xie, Gang Chen, Xiangcai Wang, Xiaobo Lai

    To overcome the limitations of conventional breast screening methods based on digital mammography, a quasi-3D imaging technique, digital breast tomosynthesis (DBT) has been developed in the field of breast cancer screening in recent years. In this work, a computer-aided architecture for mass regions segmentation in DBT images using a dilated deep convolutional neural network (DCNN) is developed. First, to improve the low contrast of breast tumour candidate regions and depress the background tissue noise in the DBT image effectively, the constraint matrix is established after top-hat transformation and multiplied with the DBT image. Second, input image patches are generated, and the data augmentation technique is performed to create the training data set for training a dilated DCNN architecture. Then the mass regions in DBT images are preliminarily segmented; each pixel is divided into two different kinds of labels. Finally, the postprocessing procedure removes all false-positives regions with less than 50 voxels. The final segmentation results are obtained by smoothing the boundaries of the mass regions with a median filter. The testing accuracy (ACC), sensitivity (SEN), and the area under the receiver operating curve (AUC) are adopted as the evaluation metrics, and the ACC, SEN, as well as AUC are 86.3%, 85.6%, and 0.852 for segmenting the mass regions in DBT images on the entire data set, respectively. The experimental results indicate that our proposed approach achieves promising results compared with other classical CAD-based frameworks.


  • Open Access

    Tumor Grade and Overall Survival Prediction of Gliomas Using Radiomics

    by Jianming Ye, He Huang, Weiwei Jiang, Xiaomei Xu, Chun Xie, Bo Lu, Xiangcai Wang, Xiaobo Lai

    Glioma is one of the most common and deadly malignant brain tumors originating from glial cells. For personalized treatment, an accurate preoperative prognosis for glioma patients is highly desired. Recently, various machine learning-based approaches have been developed to predict the prognosis based on preoperative magnetic resonance imaging (MRI) radiomics, which extract quantitative features from radiographic images. However, major challenges remain for methodologic developments to optimize feature extraction and provide rapid information flow in clinical settings. This study investigates two machine learning-based prognosis prediction tasks using radiomic features extracted from preoperative multimodal MRI brain data: (i) prediction of tumor grade (higher-grade vs. lower-grade gliomas) from preoperative MRI scans and (ii) prediction of patient overall survival (OS) in higher-grade gliomas ( 12 months) from preoperative MRI scans. Specifically, these two tasks utilize the conventional machine learning-based models built with various classifiers. Moreover, feature selection methods are applied to increase model performance and decrease computational costs. In the experiments, models are evaluated in terms of their predictive performance and stability using a bootstrap approach. Experimental results show that classifier choice and feature selection technique plays a significant role in model performance and stability for both tasks; a variability analysis indicates that classification method choice is the most dominant source of performance variation for both tasks.